Latest news
- Top news from MedWatch this week –
- Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps –
- China accepts regulatory filing for ALK allergy tablet –
- Another hurdle overcome in delaying MDR deadline –
- Dupixent becomes ninefold blockbuster –
- ALK forecasts lower growth in 2023 than strong 2022 result –
- Unilabs and Siemens Healthineers enter million-euro strategic partnership –
- Coloplast launches male catheter featuring new technology –
- Novo Nordisk hopes to retain employees with share gift –
- Coloplast's bottom line disappoints in otherwise strong report –
